385 research outputs found
Staging chronic pancreatitis with exocrine function tests: Are we better?
Chronic pancreatitis (CP) is an inflammatory disease of the pancreas evolving in progressive fibrotic disruption of the gland with exocrine and endocrine pancreatic insufficiency. Although imaging features of CP are well known, their correlation with exocrine pancreatic function tests are not obvious, particularly in the early stage of the disease. There are many clinical classification of CP, all suggested for better distinguish and manage different forms based on etiological and clinical factors, and severity of the disease. Recently, a new classification of CP has been suggested: the M-ANNHEIM multiple risk factor classification that includes etiology, stage classification and degree of clinical severity. However, more accurate determination of clinical severity of CP requires a correct determination of exocrine function of the pancreas and fecal fat excretion. Recently, Kamath et al demonstrated that the evaluation of exocrine pancreatic function by acid steatocrit and fecal elastase-1 (EF-1) was helpful, but EF-1 was able to detect exocrine pancreatic insufficiency in more patients, upgrading some patients in higher stage of disease according to M-ANNHEIM classification. So, EF-1 is a more accurate test to determine exocrine pancreatic insufficiency and to stage chronic pancreatitis in the M-ANNHEIM classification. On the contrary, EF-1 determination shows low sensitivity in detecting exocrine pancreatic insufficiency in early stage of the disease
Pancreatic resection in very elderly patients: A critical analysis of existing evidence
The aging of the population results in a rise of number of elderly patients (aged 80 years and older) with pancreatic or periampullary cancer, and more pancreatectomies could eventually be performed in such complex patients. However, early and long-term results after pancreatic resection in octogenarians are still controversial, and may trouble the surgeon when approaching this type of population. Evaluation of reported experiences shows that for almost all Authors, pancreatectomy can be performed safely in elderly population, although overall morbidity and mortality rates were 34.9% and 13.2% respectively, with a mean length of hospital stay of 18 d. These features appear higher in older patients compared to the younger counterpart. Less than 50% of patients underwent adjuvant therapy after operation. Long-term survival is reported not significantly different in aged 80 years and older patients, with a median overall survival time of 17.6 mo. The quality of life after pancreatic resection is only sporadically evaluated but, when considered, it highlights the need of health facility service after operation for these "frail" patients. Prospective studies on the quality of life of pancreatectomized octogenarians are welcome. Proper selection of patients, geriatric assessment with multidisciplinary approach, centralization of pancreatic surgery in high-volume centres and rehabilitation programs after surgery appear to be crucial points in order to improve surgical treatments of pancreatic tumors in very elderly patients
Thymoma metastatic to liver and pancreas: case report and review of the literature
A 71-year-old man presented with a thymic mass involving the superior vena cava. A mediastinoscopical biopsy initially suggested a diagnosis of type A thymoma. After neoadjuvant chemotherapy, the patient underwent en-bloc thymectomy and vascular resection for a pathology-confirmed type B3 thymoma involving the superior vena cava, the left brachiocephalic vein and the distal part of the right brachiocephalic vein. Adjuvant radiotherapy was administered. Two years after the primary surgery, abdominal computed tomography (CT) and whole body fluorodeoxyglucose (18-FDG) positron emission tomography (PET) scans showed a single hepatic lesion that was treated with wedge liver resection. Pathological examination confirmed metastatic type B3 thymoma. Almost 4 years later, abdominal CT and 18-FDG PET revealed a 2.9-cm solid mass involving the body of the pancreas. Distal pancreatectomy with lymph node dissection was performed. Pathological examination showed a pancreatic metastasis from a type B3 thymoma, without lymph node involvement. The patient is alive and free of disease 6 months after the pancreatectomy (68 months after the initial thymectomy surgery). Intra-abdominal recurrence and pancreatic metastases are very uncommon manifestations of thymoma, but this event should be kept in mind when an abdominal mass is seen during follow-up
An Easier Technique for End to End Pancreatlcojejunostomy
Breakdown of the pancreaticoenterostomy is responsible for a number of complications and for the
high mortality associated with pancreaticoduodenectomy. Although in recent years the postoperative
mortality has dropped to less than 10% and in some to less than 5%, pancreatic fistula remains
the most common and troublesome complication
PET/CT incidental detection of second tumor in patients investigated for pancreatic neoplasms
Positron Emission Tomography/computed tomography (PET/CT) is an imaging technique which has a role in the detection and staging malignancies (both in first diagnosis and follow-up). The finding of an unexpected region of FDG (Fluorodeoxyglucose) uptake can occur when performing whole-body FDG-PET, raising the possibility of a second primary tumor. The aim of this study was to evaluate our experience of second primary cancer incidentally discovered during PET/CT examination performed for pancreatic diseases, during the initial work-up or follow-up after surgical resection
Mesenteric-Portal Vein Resection during Pancreatectomy for Pancreatic Cancer
The aim of the present study was to determine the outcome of patients undergoing pancreatic resection with (VR+) or without (VR 12) mesenteric-portal vein resection for pancreatic carcinoma. Between January 1998 and December 2012, 241 patients with pancreatic cancer underwent pancreatic resection: in 64 patients, surgery included venous resection for macroscopic invasion of mesenteric-portal vein axis. Morbidity and mortality did not differ between the two groups (VR+: 29% and 3%; VR 12: 30% and 4.0%, resp.). Radical resection was achieved in 55/64 (78%) in the VR+ group and in 126/177 (71%) in the VR 12 group. Vascular invasion was histologically proven in 44 (69%) of the VR+ group. Survival curves were not statistically different between the two groups. Mean and median survival time were 26 and 15 months, respectively, in VR 12 versus 20 and 14 months, respectively, in VR+ group . In the VR+ group, only histologically proven vascular invasion significantly impacted survival , while, in the VR 12 group, R0 resection and tumor\u2019s grading significantly influenced long-term survival. Vascular resection during pancreatectomy can be performed safely, with acceptable morbidity and mortality. Long-term survival was the same, with or without venous resection. Survival was worse for patients with histologically confirmed vascular infiltration
Solid-pseudopapillary tumor of the pancreas: A single center experience
open6noAim of this study was to review the institutional experience of solid-pseudopapillary tumors of the pancreas with particular attention to the problems of preoperative diagnosis and treatment. From 1997 to 2013, SPT was diagnosed in 18 patients among 451 pancreatic cystic neoplasms (3.7%). All patients underwent preoperative abdominal ultrasound, computed assisted tomography, and tumor markers (CEA and CA 19-9) determinations. In some instances, magnetic resonance, positron emission tomography, and endoscopic ultrasound with aspiration cytology were performed. There were two males and 16 females. Serum CA 19-9 was slightly elevated in one case. Preoperative diagnosis was neuroendocrine tumor (n = 2), mucinous tumor (n = 2), and SPT (n = 14). Two patients underwent previous operation before referral to our department: one explorative laparotomy and one enucleation of SPT resulting in surgical margins involvement. All patients underwent pancreatic resection associated with portal vein resection (n = 1) or liver metastases (n = 1). One patient died of metastatic disease, 77 months after operation, and 17 are alive and free with a median survival time of 81.5 months (range 36-228 months). Most of SPT can be diagnosed by CT or MRI, and the role of other diagnostic tools is very limited. We lack sufficient information regarding clinicopathologic features predicting prognosis. Caution is needed when performing limited resection, and long and careful follow-up is required for all patients after surgery.openBeltrame, Valentina; Pozza, Gioia; Dalla Bona, Enrico; Fantin, Alberto; Valmasoni, Michele; Sperti, CosimoBeltrame, Valentina; Pozza, Gioia; DALLA BONA, Enrico; Fantin, Alberto; Valmasoni, Michele; Sperti, Cosim
Collision of ductal adenocarcinoma and neuroendocrine tumor of the pancreas: a case report and review of the literature
Background: Simultaneous occurrence of exocrine and neuroendocrine tumors of the pancreas is very infrequent.
We report a patient with an endocrine tumor in the pancreatic-duodenal area and extensive exocrine carcinoma
involving the whole pancreas.
Case presentation: A 69-year-old woman was hospitalized in May 2016 for epigastric pain and weight loss. Her past
medical history revealed an undefined main pancreatic duct dilation that was subsequently confirmed at CT scan
(23 mm) and endoscopic ultrasound. There was no evidence of pancreatic masses, but the cephalic portion of the
main pancreatic duct presented hypoechoic nodules. A diagnosis of the main-duct intraductal papillary mucinous
neoplasm was made, and the patient underwent total pancreatectomy. Pathological examination showed a collision
tumor constituted by a ductal adenocarcinoma involving the whole pancreas and a neuroendocrine tumor located in
the duodenal peripancreatic wall and the head of the pancreas. There was one peripancreatic lymph node metastasis
from the ductal adenocarcinoma and eight node metastases from the neuroendocrine tumor. These findings
suggested a diagnosis of collision of neuroendocrine and ductal adenocarcinomas of the pancreas. The postoperative
course was uneventful.
Conclusions: The coexistence of pancreatic endocrine and exocrine tumors is very uncommon. When present,
problems in differential diagnosis may arise between mixed exocrine-endocrine carcinoma or the collision of separate
tumors
Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer
AIM
To analyze the importance of para-aortic node status in a series of patients who underwent pancreaticoduodenectomy (PD) in a single Institution.
METHODS
Between January 2000 and December 2012, 151 patients underwent PD with para-aortic node dissection for pancreatic adenocarcinoma in our Institution. Patients were divided into two groups: patients with negative PALNs (PALNs-), and patients with metastatic PALNs (PALNs+). Pathologic factors, including stage, nodal status, number of positive nodes and lymph node ratio, invasion of para-aortic nodes, tumor\u2019s grading, and radicality of resection were studied by univariate and multivariate analysis. Survival curves were constructed with Kaplan-Meier method and compared with Log-rank test: significance was considered as P < 0.05.
RESULTS
A total of 107 patients (74%) had nodal metastases. Median number of pathologically assessed lymph nodes was 26 (range 14-63). Twenty-five patients (16.5%) had para-aortic lymph node involvement. Thirty-three patients (23%) underwent R1 pancreatic resection. One-hundred forty-one patients recurred and died for tumor recurrence, one is alive with recurrence, and 9 are alive and free of disease. Overall survival was significantly influenced by grading (P = 0.0001), radicality of resection (P = 0.001), stage (P = 0.03), lymph node status (P = 0.04), para-aortic nodes metastases (P = 0.02). Multivariate analysis showed that grading was an independent prognostic factor for overall survival (P = 0.0001), while grading (P = 0.0001) and radicality of resection (P = 0.01) were prognostic parameters for disease-free survival. Number of metastatic nodes, node ratio, and para-aortic nodes involvement were not independent predictors of disease-free and overall survival.
CONCLUSION
In this experience, lymph node status and para-aortic node metastases were associated with poor survival at univariate analysis, but they were not independent prognostic factors
Przetrwała hipoglikemia hiperinsulinemiczna współistniejąca z nieaktywnym wyspiakiem trzustki
The most common cause of hyperinsulinaemic hypoglycaemia in adult is insulinoma. Although nesidioblastosis is a rare but well-recognised disorder of persistent hypoglycaemia in infants, it is extremely rare in adults.
We present a case of a 59-year-old woman with small neuroendocrine tumour of the tail of the pancreas, diagnosed by CT scans and MRI, and hypoglycaemic syndrome. Laparoscopic distal pancreatectomy was performed, and pathologic examination showed a well-differentiated, non-functioning endocrine tumour of the pancreas and diffuse nesidioblastosis in the remnant gland. In the early postoperative period, recurrent hypoglycaemia occurred in spite of oral diazoxide therapy. Plasma proinsulin levels were extremely high. 18F-DOPA positron emission tomography showed a pathologic uptake of tracer in the head and the uncinate process of the pancreas. Subtotal pancreatectomy was suggested but the patient refused operation: she is taking diazoxide 100 mg three times daily.
Coexistence of nesidioblastosis with a neuroendocrine tumour makes preoperative diagnosis and management of severe hypoglycaemia more difficult. Nesidioblastosis should be considered in differential diagnosis of hypoglycaemic syndrome, but histological examination is necessary for a definitive tissue diagnosis. (Endokrynol Pol 2015; 66 (4): 356–360)
Najczęstszą przyczyną hipoglikemii hiperinsulinemicznej u osób dorosłych jest insulinoma. Chociaż przetrwała hipoglikemia hiperinsulinemiczna to rzadkie, lecz łatwo rozpoznawalne zaburzenie przetrwałej hipoglikemii u noworodków, bardzo rzadko występuje u osób dorosłych. Autorzy badania przedstawiają przypadek 59-letniej kobiety z niewielkim guzem neuroendokrynnym ogona trzustki, zdiagnozowanym dzięki tomografii komputerowej oraz rezonansowi magnetycznemu, oraz zespołem hipoglikemicznym. Wykonano laparoskopową dystalną pankreatektomię, a badanie patologiczne wykazało wysoko zróżnicowanego, nieaktywnego, endokrynnego wyspiaka trzustki oraz rozlaną przetrwałą hipoglikemię hiperinsulinemiczną w pozostałej części gruczołu. We wczesnym okresie pooperacyjnym wystąpiła nawracająca hipoglikemia, mimo stosowania doustnego leczenia diazoksydem. Stężenie proinsuliny w osoczu był bardzo wysoki. Pozytonowa tomografia emisyjna z 18F-DOPA wykazała patologiczną absorpcję znacznika w głowie i wyrostku haczykowatym trzustki. Sugerowano subtotalną pankreatektomię, lecz pacjentka nie zgodziła się na operację: przyjmowała dawkę 100 mg diazoksydu trzy razy dziennie. Współistnienie przetrwałej hipoglikemii hiperinsulinemicznej z nowotworem neuroendokrynnym utrudnia diagnostykę przedoperacyjną i leczenie ciężkiej hipoglikemii. Przetrwała hipoglikemia hiperinsulinemiczna powinna być brana pod uwagę w diagnozie różnicującej zespół hipoglikemiczny, lecz badanie histologiczne jest niezbędne do definitywnej diagnozy tkanek. (Endokrynol Pol 2015; 66 (4): 356–360)
- …